Please login to the form below
Vaccibody name Martin Bonde as CEO
He joins from EpiTherapeutics where he holds the same role
Norwegian cancer vaccine company Vaccibody has appointed Dr Martin Bonde as CEO, effective from August 10.
Bonde has over 25 years of international experience in the biotech industry, starting his career at Dako and going on to work at companies including Ostemeter, Visiopharm and Aros Pharma.
He joins from EpiTherapeutics, where he has held the role of CEO since 2009.
Tom Pike, chairman of Vaccibody, said: "We are delighted to welcome Martin Bonde to Vaccibody. The Vaccibody technology has a wide business development potential within many market segments, which will benefit greatly from Martin's extensive track record in deal making.
“We also believe that our ability to attract an experienced industry executive with Martin's credentials reflect positively on Vaccibody's' considerable potential”.
Bonde's experience in the sector includes a number of transactions within business development, trade sales, mergers and acquisitions and management of research and development.
Featured jobs
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Science Writer – Healthcare Advertising
-
Salary TBC
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Account Director, Training & Medical Communications, London
-
Competitive Salary
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Moving annual total (MAT)
- Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat
- Key success factor (KSF)
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- Chiesi targets patient adherence via mobile app
- PEGASUS OPENS THE HEALTHCARE INSIGHTS STAGE AT CANNES LIONS
- May earmarks £20bn for the NHS - but experts say it's not enough
- Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more
- New trial results suggest CAR-T effects are durable in lymphoma
- Evotec says Sanofi deal makes it anti-infectives powerhouse
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- Australian Flu and the dilemma of naming diseases
- ...
- Wearables and Healthcare
- What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
- What does a future-proof rep look like?
- Businesses can no longer afford to push ahead with the traditional Key Account Management model....
Quick links
Infographics
